The trajectory of Viagra, initially marketed by copyright, presents a complex case study for investors considering the pharmaceutical landscape . Although its early success and impact of billions in revenue , the intellectual property expiration has opened the way for competing medications, greatly eroding earnings opportunities. This shift raises